Pharma and US Import Annexes
Question: Would anyone have insight into the latest Annex I (Sept 25th, EU import exclusions) and potential proposed Annex III exclusions for Pharma? We are wondering if some of our raw materials, which are used in Pharma applications and also for Medical Device manufacturing downstream, might be able to take advantage of the ‘Pharma’ scope. We aren’t […]